RESEARCH TRIANGLE PARK – Alex Arfaei, a former managing director with BMO Capital Markets, has joined an expanding Pappas Ventures as a partner
At BMO, Arfaei was an equity research analyst focusing on pharmaceutical and biotech firms. Pappas is tasking him to help “identify and evaluate investment opportunities.” He previously worked at FBR Capital Markets, Endo Pharmaceuticals and Merck. Arfaei earned an MBA at Duke University.
Pappas only invests in life science companies.
Pappas Capital promotes 2 members in ‘next phase’ of VC firm’s ‘evolution’
“Alex’s unique combination of equity research and industry operating experience will significantly benefit our team as we seek to source innovative investment opportunities for the current and future Pappas Ventures funds,” said Art Pappas, the founder and Managing Partner of Pappas Capital. “We are pleased to welcome Alex to Pappas as we continue to execute on our mission of delivering superior returns for our clients by investing in companies creating the next generation of life science products and technologies.”
Pappas Ventures recently promoted Kyle Rasbach to Managing Partner and Matthew Boyer to Chief Financial Officer. Tom Mathers also recently joined the firm as a partner.
Pappas Ventures is part of Pappas Capital.
